AIDS-Related Complex - 275 Studies Found Completed : A Randomized Trial to Evaluate the Safety and Efficacy of Combination Therapy With Retrovir ( AZT ) and HIVID ( ddC ) Versus Retrovir, HIVID, and Wellferon ( Interferon Alfa-n1 ) for the Treatment of HIV Infection : HIV Infections : 1999-11-02 : Drug: Zidovudine Drug: Zalcitabine Completed : Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study : Mycobacterium Avium-intracellulare Infection HIV Infections : 1999-11-02 : Drug: Rifabutin Completed : Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure : HIV Infections Kidney Failure, Chronic : 1999-11-02 : Drug: Zidovudine Completed : A Safety, Pilot Pharmacokinetics and Neurocognitive Study of AS-101 in Combination With Zidovudine in AIDS/ARC Patients : HIV Infections : 1999-11-02 : Drug: Zidovudine Drug: AS-101 Completed : The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks : HIV Infections : 1999-11-02 : Drug: Stavudine Drug: Zidovudine Completed : A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected Infants : HIV Infections Pneumococcal Infections : 1999-11-02 : Biological: Pneumococcal Vaccine, Polyvalent (23-valent) Completed : Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S) : HIV Infections : 1999-11-02 : Drug: Delavirdine mesylate Drug: Zidovudin Completed : A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV : HIV Infections : 1999-11-02 : Drug: Glycovir Drug: Zidovudine Completed : Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3 : HIV Infections : 1999-11-02 : Drug: Lymphocytes, Activated Completed : A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3 : HIV Infections : 1999-11-02 : Drug: Interferon alfa-2a Drug: Zidovudine <<< Previous | Next >>>
